跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 121 条关于
“Ugur Sahin”
全部
121
临床试验
68
药物
21
机构
16
资讯
16
6个月前
BioNTech Co-Founders Sahin and Türeci to Establish New mRNA Company by 2026
5个月前
BioNTech to Close Singapore Manufacturing Plant by February 2027 Amid Revenue Decline
11个月前
BioNTech Secures German Regulatory Approval for $1.25 Billion CureVac Acquisition
去年
BioNTech to Acquire Biotheus, Bolstering Oncology Pipeline with Bispecific Antibody
2年前
Pfizer and BioNTech's Combination mRNA Vaccine Shows Promise Against Influenza A and COVID-19
去年
BioNTech Chief Strategy Officer Ryan Richardson to Step Down After Seven-Year Tenure
去年
BioNTech Advances Oncology Pipeline with BNT327/PM8002 and mRNA Immunotherapies
去年
Bristol Myers Squibb Partners with BioNTech in $11.1 Billion Deal for Dual-Target Cancer Immunotherapy
去年
BioNTech to Acquire CureVac for $1.25 Billion to Strengthen mRNA Cancer Immunotherapy Pipeline
5年前
mRNA Vaccines: How Moderna and Pfizer-BioNTech Revolutionized COVID-19 Immunization
第 1 页,共 2 页
上一页
下一页